Rajesh Krishnan - 03 Jan 2024 Form 4 Insider Report for Oncternal Therapeutics, Inc.

Signature
/s/Chase C. Leavitt, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
03 Jan 2024
Net transactions value
-$5,873
Form type
4
Filing time
05 Jan 2024, 16:00:33 UTC
Previous filing
04 Oct 2023
Next filing
15 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Tax liability $5,873 -11,838 -21% $0.4961 44,019 03 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.